Patent · US Active

Amlexanox analogs

US10214536B2 · kind B2 · utility

0Cited by

55References

4Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Hollis D. Showalter · Ann Arbor, US
Alan R. Saltiel · Ann Arbor, US
John J. Tesmer · Ann Arbor, US
Xinmin Gan · Ann Arbor, US

Key dates

Filing date	Jan 27, 2017
Grant date	Feb 26, 2019
Priority date	—
Expiry date	Jan 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/147
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are amlexanox analogs and methods for the treatment and/or prevention of diabetes, impaired insulin signaling, obesity, or other related diseases and conditions therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.